Discover 1,005 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Minneapolis currently offers various active clinical trials with a focus on many chronic conditions, including asthma, arthritis, kidney disease, and hidradenitis suppurativa. The city’s leading healthcare institutions are recruiting participants to take part in paid research studies as healthy volunteers, as well as those looking for studies targeting specific health issues, providing access to innovative treatments and contributing to the development of new therapies.
Filter
2
Filter results
Results: 1,005
New
State Representation in Early Psychosis 2
for
Early Psychosis, Psychosis, Schizophrenia,
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 15 - 45
Code: NCT07834203
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Location: Minneapolis MN, Chicago IL, Fairway KS, Syracuse NY,
Sponsor: Nkarta, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06733935
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Minneapolis MN, Fairway KS, Detroit MI, Grand Rapids MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase 1, Recruiting
The SEAS Study: Sensory Engagement and Activation During Noninvasive Stimulation
for
Healthy Adult Participants
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18 - 65
Code: NCT07606573
Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Minneapolis MN, West Dundee IL, Chicago IL,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase 3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations